ARTOURA Breast Tissue Expander medical device reports that FDA received
- Name type
- Device brand name, as written on reports
- Generic name
- Expander skin inflatable
- Device type
- Tissue expander and accessories (product code LCJ)
- Manufacturer given most often on reports
- Mentor Texas
What a report is
A report is not proof that the device was the cause of the event.
FDA says:
Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Device Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .
FDA also says:
Although MDRs are a valuable source of information, this passive surveillance system has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data. In addition, the incidence or prevalence of an event cannot be determined from this reporting system alone due to potential under-reporting of events and lack of information about frequency of device use.
Source: openFDA, Device Adverse Event Overview. The site read the page on .
MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.
Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .
Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.
Reports on file
From January 2018 to July 2026, FDA received 314 medical device reports that name the brand ARTOURA Breast Tissue Expander. A brand name is as the reporter or the manufacturer wrote it, so one product can have more than one spelling.
FDA received 8 reports in the 12 months to September 2026 and 1 in the 12 months before. FDA releases MAUDE data every month. Reports can arrive months after an event, so the newest months grow in later releases.
Of the 3,444,740 device reports that FDA received in the 12 months to September 2026, 8 (under 0.1%) name the brand ARTOURA Breast Tissue Expander. Manufacturer reports were 99.4% of the reports that name this brand and 94.9% of all device reports.
The number of people who use the product is not in the data. A count is not a rate. A count of reports is not a count of events or of patients, because one event can have more than one report.
What an MDR is
A medical device report: one submission to FDA about one event. It has the brand name, the generic name, the manufacturer, the product code, the event type and coded problems. Manufacturers and user facilities must send reports.
Data version
openFDA MAUDE release of 23 Oct 2026. Reports received through 30 Sep 2026.
Since the last update
FDA says:
MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.
Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .
The latest update of the FDA data, recorded on , changed no count of this page.
- In April to June 2026, FDA received 4 reports that name the brand ARTOURA Breast Tissue Expander.
- In January to March 2026, FDA received 1.
- In April to June 2025, FDA received 0.
April to June 2026 is the latest closed quarter in the data. A closed quarter is a quarter for which the FDA files have most of the reports.
Event types by year
The event type is the classification that the reporter gave. The four terms are FDA's.
FDA says:
MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.
Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .
Reports that name ARTOURA Breast Tissue Expander, by event type and by the year in which FDA received them
The table continues to the right.
| Year | Reports | Death | Injury | Malfunction | Other | Not given |
|---|---|---|---|---|---|---|
| 2018 | 63 | 0 | 54 | 9 | 0 | 0 |
| 2019 | 74 | 0 | 73 | 1 | 0 | 0 |
| 2020 | 96 | 0 | 84 | 12 | 0 | 0 |
| 2021 | 40 | 0 | 34 | 6 | 0 | 0 |
| 2022 | 15 | 0 | 15 | 0 | 0 | 0 |
| 2023 | 14 | 0 | 11 | 3 | 0 | 0 |
| 2024 | 4 | 0 | 4 | 0 | 0 | 0 |
| 2026 | 8 | 0 | 8 | 0 | 0 | 0 |
An event type in a report is not proof that the device was the cause. FDA does not verify the event type.
Malfunction
A malfunction report says that the device did not do what it was made to do. It can be with or without harm to a person.
Reports by month
FDA releases MAUDE data every month. Reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
| Event type | Reports | Share | Share as a bar |
|---|---|---|---|
| Death | 0 | 0% | |
| Injury | 283 | 90.1% | |
| Malfunction | 31 | 9.9% | |
| Other | 0 | 0% | |
| Not given | 0 | 0% |
| Report source | Reports | Share | Share as a bar |
|---|---|---|---|
| Manufacturer report | 312 | 99.4% | |
| Voluntary report | 1 | 0.3% | |
| User facility report | 0 | 0% | |
| Distributor report | 0 | 0% | |
| Not given | 1 | 0.3% |
Each share is of the 314 reports that name this brand, not of the devices in use.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Material rupture | 244 | 77.7% |
| Off-label use | 14 | 4.5% |
| Device damaged prior to receipt by user | 6 | 1.9% |
| Material separation | 6 | 1.9% |
| Defective devicethe device was defective | 5 | 1.6% |
| Migrationthe device moved from where it was placed | 5 | 1.6% |
| Delivered as unsterile product | 4 | 1.3% |
| Connection problema connection problem | 3 | 1% |
| Inflation problem | 3 | 1% |
| Unsealed device packaging | 3 | 1% |
| Defective component | 2 | 0.6% |
| Deflation problem | 2 | 0.6% |
| Filling problem | 2 | 0.6% |
| Infusion or flow problema problem with flow or infusion | 2 | 0.6% |
| Insufficient device problem information | 2 | 0.6% |
| Packaging problem | 2 | 0.6% |
| Device contaminated during manufacture or shipping | 1 | 0.3% |
| Device contamination with chemical or other material | 1 | 0.3% |
| Expulsion | 1 | 0.3% |
| Fracturea broken bone | 1 | 0.3% |
These are the device problem codes of FDA, as written on the report. One report can have more than one code. The table leaves out general codes such as "no apparent adverse event".
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Deformity/ disfigurement | 51 | 16.2% |
| Post operative wound infection | 10 | 3.2% |
| Capsular contracturescar tissue tightening around an implant | 6 | 1.9% |
| No patient involvement | 6 | 1.9% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 4 | 1.3% |
| Painpain, site not specified | 4 | 1.3% |
| Seromaa collection of fluid under the skin | 4 | 1.3% |
| Local reaction | 3 | 1% |
| Necrosisdeath of tissue | 3 | 1% |
| Breast cancerbreast cancer | 2 | 0.6% |
| Cancer | 2 | 0.6% |
| Hematomaa collection of blood under the skin or in tissue | 2 | 0.6% |
| Wound dehiscencea wound reopened | 2 | 0.6% |
| Abscessa collection of pus | 1 | 0.3% |
| Breast discomfort/pain | 1 | 0.3% |
Patient problem codes are mainly in reports sent since 2019, and the field is often empty.
Pages near this one
- Mentor Cpx 4 Breast Tissue Expander same device type
- MENTOR CPX 4 Breast Tissue Expander with Suture Tabs same device type
- MENTOR Tissue Expander same device type
- Unk Tissue Expander same device type
- Artisan? MRI next in the A to Z list
- As Lvp 20d 2ss Cv next in the A to Z list
- Artisan? next in the A to Z list
- As Lvp 20d 3ss Cv next in the A to Z list
- Artis zee floor next in the A to Z list
- As Lvp 20d Dehp 2ss Cv next in the A to Z list
- Artis Zee Ceiling next in the A to Z list
- As Lvp 20d Dehp 3ss Cv next in the A to Z list
These links are for navigation. No count selected them. The page of the device type lists each brand name with product code LCJ.
Official pages
- Medical Device Reporting (MDR): How to Report Medical Device ProblemsThe FDA page that tells how to report a problem with a medical device.
- MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
- Manufacturer and User Facility Device Experience (MAUDE) DatabaseThe search page of FDA for the device reports.
The site checked these addresses on . The links open in a new tab.
Cite this page
Reported Reactions. ARTOURA Breast Tissue Expander: medical device reports that FDA received. https://reportedreactions.com/device/artoura-breast-tissue-expander/ Source: U.S. Food and Drug Administration, openFDA Device Adverse Event (MAUDE) files, release of . Reports received through .
Where the data come from
The counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. Brand names, generic names and manufacturer names are as written on the reports. The names of the product codes come from the device classification of FDA.
A report is in the count when a device in it has this brand name, after the site removes differences of punctuation and capital letters. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.
Questions
Do these reports show that ARTOURA Breast Tissue Expander was at fault?
No. FDA says:
The submission of an MDR itself does not necessarily demonstrate that the device caused or contributed to the adverse outcome or event.
Source: FDA Center for Devices and Radiological Health, About Manufacturer and User Facility Device Experience (MAUDE) Database. Content current as of . The site read the page on .
Confirming whether a device actually caused a specific event can be difficult based solely on information provided in a given report.
Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .
What event types do the reports record?
Injury (283) and malfunction (31). The event type is the classification that the reporter gave: death, injury, malfunction or other. FDA does not verify it.
Who sent these reports?
Manufacturer reports (99.4%) and voluntary reports (0.3%). These are the sources of the reports that name this brand.
Some reports come directly from user facilities (like hospitals) or device importers (distributors), while others come directly from manufacturers.
Source: openFDA, Device Adverse Event Overview. The site read the page on .
How does a person report a problem with a medical device?
FDA runs MedWatch, a program that takes voluntary reports about medical devices. The guide on how to report has the links.